Manulife (Manufacturers Life Insurance)
KPTI icon

Manulife (Manufacturers Life Insurance)’s Karyopharm Therapeutics KPTI Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,391
Closed -$54.2K – 3012
2024
Q1 		$54.2K Buy
+2,391
New +$41.9K ﹤0.01% 2879
2023
Q4 		– Sell
-3,139
Closed -$63.1K – 2995
2023
Q3 		$63.1K Hold
3,139
– – ﹤0.01% 2918
2023
Q2 		$84.3K Buy
3,139
+1,222
+64% +$52.6K ﹤0.01% 2903
2023
Q1 		$112K Hold
1,917
– – ﹤0.01% 2714
2022
Q4 		$97.8K Sell
1,917
-18
-0.9% -$1.25K ﹤0.01% 2803
2022
Q3 		$158K Sell
1,935
-53
-3% -$3.96K ﹤0.01% 2683
2022
Q2 		$135K Buy
1,988
+21
+1% +$1.93K ﹤0.01% 2820
2022
Q1 		$217K Sell
1,967
-586
-23% -$73K ﹤0.01% 2720
2021
Q4 		$246 Sell
2,553
-59
-2% -$5.88K ﹤0.01% 2761
2021
Q3 		$228K Sell
2,612
-66
-2% -$6.85K ﹤0.01% 2891
2021
Q2 		$415K Sell
2,678
-44
-2% -$6.39K ﹤0.01% 2568
2021
Q1 		$430K Sell
2,722
-2
-0.1% -$421 ﹤0.01% 2384
2020
Q4 		$632K Buy
2,724
+83
+3% +$19.2K ﹤0.01% 2065
2020
Q3 		$578K Sell
2,641
-49
-2% -$12K ﹤0.01% 1930
2020
Q2 		$726K Buy
2,690
+254
+10% +$75.1K ﹤0.01% 1773
2020
Q1 		$702K Buy
2,436
+171
+8% +$47.2K ﹤0.01% 1669
2019
Q4 		$651K Sell
2,265
-122
-5% -$26.5K ﹤0.01% 1902
2019
Q3 		$352K Sell
2,387
-10
-0.4% -$1.36K ﹤0.01% 2224
2019
Q2 		$215K Buy
2,397
+233
+11% +$18.7K ﹤0.01% 2597
2019
Q1 		$190K Buy
2,164
+144
+7% +$16K ﹤0.01% 2455
2018
Q4 		$284K Sell
2,020
-50
-2% -$8.43K ﹤0.01% 2184
2018
Q3 		$529K Sell
2,070
-274
-12% -$75.7K ﹤0.01% 2250
2018
Q2 		$598K Buy
2,344
+615
+36% +$152K ﹤0.01% 2245
2018
Q1 		$348K Sell
1,729
-53
-3% -$10.6K ﹤0.01% 2602
2017
Q4 		$256K Buy
1,782
+43
+2% +$6.91K ﹤0.01% 2827
2017
Q3 		$287K Sell
1,739
-55
-3% -$7.88K ﹤0.01% 2696
2017
Q2 		$243K Buy
1,794
+373
+26% +$55.2K ﹤0.01% 2853
2017
Q1 		$274K Buy
1,421
+190
+15% +$30.5K ﹤0.01% 2611
2016
Q4 		$173K Buy
1,231
+117
+11% +$15.8K ﹤0.01% 2898
2016
Q3 		$162K Sell
1,114
-23
-2% -$2.76K ﹤0.01% 2930
2016
Q2 		$115K Buy
1,137
+115
+11% +$14.9K ﹤0.01% 3158
2016
Q1 		$133K Buy
1,022
+25
+3% +$2.76K ﹤0.01% 2888
2015
Q4 		$198 Buy
997
+27
+3% +$5.85K ﹤0.01% 2674
2015
Q3 		$153 Buy
970
+21
+2% +$5.62K ﹤0.01% 2868
2015
Q2 		$387 Buy
949
+310
+49% +$134K ﹤0.01% 2300
2015
Q1 		$293 Buy
639
+88
+16% +$37.9K ﹤0.01% 2449
2014
Q4 		$309 Sell
551
-14
-2% -$7.95K ﹤0.01% 2325
2014
Q3 		$296 Buy
565
+56
+11% +$31.6K ﹤0.01% 2350
2014
Q2 		$355K Buy
509
+135
+36% +$62.8K ﹤0.01% 2297
2014
Q1 		$174 Buy
+374
New +$190K ﹤0.01% 2816

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KPTI Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 2,391 shares — an estimated $54.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in KPTI in Q1 2014 and held it in 40 quarters. The position peaked at $726K in Q2 2020. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,391 Karyopharm Therapeutics shares in Q2 2024, an estimated $54.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Karyopharm Therapeutics in Q1 2014 and held it in 40 quarters.
  • Manulife (Manufacturers Life Insurance)'s Karyopharm Therapeutics position peaked at $726K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.